fda warning letters glp-1 october 2025 US Letters: Considerations for LDTs including Timelines FDA Sends Warning Letters to
Description
Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trumps most-favored nation pricing plan
Learn the expert-approved nutrition plan that helps reduce side effects and keeps weight off for good.
Clinician-written guides on GLP-1s, phentermine, metabolism, safe weight loss, and progress tracking
Pills that work in a similar way could be a cheaper, simpler solution.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Researchers and leading pharma scientists now ask: could GLP-1s be our first true longevity drugs
